BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2804809
Number of visits today
1369
Number of downloads
2057907
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Onugwu AL, Attama AA, Nnamani PO, Onugwu SO, Onuigbo EB, Khutoryanskiy VV. Development and optimization of solid lipid nanoparticles coated with chitosan and poly(2-ethyl-2-oxazoline) for ocular drug delivery of ciprofloxacin. Journal of Drug Delivery Science and Technology 2022;74:103527. [DOI: 10.1016/j.jddst.2022.103527] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Albasri OWA, Kumar PV, Rajagopal MS. Development of Computational In Silico Model for Nano Lipid Carrier Formulation of Curcumin. Molecules 2023;28. [PMID: 36838817 DOI: 10.3390/molecules28041833] [Reference Citation Analysis]
2 Chapa González C, Martínez Saráoz JV, Roacho Pérez JA, Olivas Armendáriz I. Lipid nanoparticles for gene therapy in ocular diseases. Daru 2023. [PMID: 36790734 DOI: 10.1007/s40199-023-00455-1] [Reference Citation Analysis]
3 Bhattacharya S, Sharma S, Prajapati BG. Development of D-α-Tocopherol polyethylene glycol 1000 succinate fabricated nanostructural lipid carrier of sorafenib tosylate for metastatic colorectal targeting application: Stability, physical characterization, cytotoxicity, and apoptotic studies against SW48 cells PTEN. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.990841] [Reference Citation Analysis]
4 Abdellatif MM, Josef M, El-nabarawi MA, Teaima M. Sertaconazole-Nitrate-Loaded Leciplex for Treating Keratomycosis: Optimization Using D-Optimal Design and In Vitro, Ex Vivo, and In Vivo Studies. Pharmaceutics 2022;14:2215. [DOI: 10.3390/pharmaceutics14102215] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345